C. Leea

Institutional report-Cardiac general A randomized , double-blind , placebo-controlled trial of a COX-2 inhibitor ( Rofecoxib ) in patients undergoing coronary artery bypass surgery

Y. Chan, P. Wong, A. Asmat, 2006 .